This multicenter, double-blind, randomized, parallel-group fixed-dose study of 8 weeks' duration was performed to define the maximum tolerated dose of nateglinide in a prediabetic population.

The goal of this study was to assess the safety, tolerability, and metabolic effects of nateglinide in a prediabetic population and to thereby establish the feasibility of using nateglinide for a ...

Levy JC. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care. 2001 Jul;24(7):1221-5. [4]Shukla AP ...

However, its acute glucose lowering effect is comparable to other diabetic medications like Acarbose and Nateglinide. This doesn’t mean people should stop taking medications and do food order ...